Skip to content

Takeda webinar

Play Video

Restoring Hemostasis with Four Factor Prothrombin Complex Concentrates (4F-PCCs) ​in Patients Receiving Anticoagulants

Please joins us for an expert-led webinar about use of 4F-PCCs in patients receiving anticoagulants. Expert speakers will discuss the evolving landscape of oral anticoagulant, introduce 4F-PCCs and the mechanism of action, and examine the latest guideline recommendations for their use. Additionally, they will highlight ongoing research initiatives aimed at improving the understanding on the use of 4F-PCCs in anticoagulation reversal.

Please be advised that this program is a non-CME event.

Speakers

Oliver Grottke, MD, PhD, MScPH
Prof. Dr. med.,
Anesthesiologist,
Department of Anesthesiology and Intensive Care
University Hospital RWTH Aachen, Germany

Peter Turecek, PhD, PharmD
Univ.-Doz. Prof. Dr.,
Scientific Expert,
Plasma-Derived Therapies,
Global Medical Affairs,
Takeda

Angela Simon, PharmD
Associate Director,
GEO RGH – GEO PDT
Global Evidence and Outcomes
Takeda

To send a comment or question to Takeda Pharmaceutical Company Limited, please fill out the form located at https://www.takeda.com/contact-us/
To report adverse events for Takeda products, please visit www.ae-reporting.com

This webinar is initiated, organized, and funded by Takeda for the members of the European Association of Hospital Pharmacists for on-demand viewing.
Please be advised that this program is a non-CME event. ©2024 Takeda Pharmaceutical Company Limited. All rights reserved. TAKEDA® and the TAKEDA Logo® are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-81522 09/2024

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.